此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Multidisciplinary Lifestyle-enhancing Treatment for People With Severe Mental Illness in Sheltered Housing Facilities

2020年5月17日 更新者:GGZ Centraal

Multidisciplinary Lifestyle-enhancing Treatment for Long-term Severe Mentally Ill Inpatients: Sheltered Housing

Introduction and rationale:

Unhealthy eating habits and lack of physical activity are risk factors for many diseases (including metabolic syndrome) and contribute to a shortened lifespan of 15-30 years in people with severe mental illness (SMI). Literature, mainly including short-term hospitalized or outpatients, show strong positive effects of activation on both physical and mental health. However, studies in long-term care are limited. In recent years, implementation of a lifestyle enhancing treatment intervention in clinical settings in "GGz Centraal" has demonstrated to be effective. The question is whether this kind of lifestyle intervention in sheltered housing is applicable and effective.

Objectives:

This research aims to develop an appropriate lifestyle intervention for patients living in sheltered housing services of GGz Centraal, based on input of patients and directly involved. Does applying this lifestyle treatment result in a positive effect in health and quality of life of patients and what is the influence of contextual factors, personal- and disease characteristics?

Study design:

In this intervention study, we use an experimental design. Municipal locations are paired based on the number of participants to generate equal cluster sizes. These paired clusters are randomly allocated to the control or intervention arm by means of a random number generator by an independent person (not involved in this project). At the start of the lifestyle treatment patients in the experimental and control group are invited to participate in the baseline screening. After twelve months, following a post-test on all outcome measures.

Treatment intervention:

The intervention in this study consists of formulating a lifestyle intervention, by patients and directly involved, aimed at enhancing a more active and healthier lifestyle . After formulation of the plan (based on psycho education, nutrition and physical activity), it wil be executed for a twelve month period.

Hypothesis:

Hypotheses is that lifestyle enhancing treatment is associated with improved metabolic health, quality of life and reduced use of medication. Furthermore we expect that movement disorders and disease severity will be negative related in becoming more active.

研究概览

详细说明

Sample size calculation:

To calculate the sample size we use the effect size on decrease in waist circumference in the previous intervention study (d =0.51) and the same analysis (multiple regression with correction for baseline value's on age, diagnosis and disease severity). To be able to detect the same effect in the current study with a minimum 80% power as a benchmark for a fair test and a significant level of 95% (α = 0.05), a minimum sample of 124 people is required (2 groups of 62). Taking into account a response rate of 73% from the first measurement a sample size of 168 patients is required.

Analyses:

We use multilevel regression to analyze the intervention effect. Possible clustering of data within the residential locations (and thus care teams) is taken into account by using a two-level structure with the first level residential location and the patients as the second. The intervention variable is set as an independent variable against difference scores of outcome variables (T2 minus T1) and corrected for the baseline value of the outcome to prevent regression to the centre. As we are unable to randomize patients individually in the current configuration on personal and disease characteristics (gender, age, diagnosis, disease severity at the start of intervention), these factors will be corrected for in the analyses if they differ significantly(p<0.05) between intervention and control group, analysed using independent t-tests and chi-squared tests. Characteristics that differ significantly will be included as covariates in the analysis described above. Multicollinearity will be checked with correlation coefficients and collinearity statistics (tolerance and Variance Inflation Factors (VIF) values).

Missing data:

Patients who are hospitalized for more than two months will be excluded from analyses.

If baseline or follow-up data are missing for two or more measures on physical or psychiatric health, patients are excluded from the analysis as insufficient difference scores can be calculated. Patients lacking difference scores on one outcome variable, are excluded from the analysis of that particular variable.

研究类型

介入性

注册 (实际的)

177

阶段

  • 不适用

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习地点

    • Gelderland
      • Ermelo、Gelderland、荷兰、3853LC
        • Veldwijk

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

有资格学习的性别

全部

描述

Inclusion Criteria:

  • Severe Mentally Ill patients,
  • living in Sheltered Housing facilities

Exclusion Criteria:

  • Incapacitated patients,
  • without informed consent from their legal representative

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 主要用途:其他
  • 分配:随机化
  • 介入模型:并行分配
  • 屏蔽:无(打开标签)

武器和干预

参与者组/臂
干预/治疗
无干预:照常治疗
实验性的:Lifestyle treatment
Lifestyle treatment

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Metabolic Health: Waist circumference
大体时间:12 months
measured halfway between the iliac crest and lowest rib in standing position
12 months

次要结果测量

结果测量
措施说明
大体时间
Metabolic Health: weight
大体时间:12 months
weight measured to the nearest 0.1kg
12 months
Metabolic Health: blood pressure
大体时间:12 months
measured systolic and diastolic blood pressure (mmHg)
12 months
Metabolic Health:Lipids
大体时间:12 months
values in blood sample
12 months
Metabolic Health:Fasting glucose
大体时间:12 months
values in blood sample
12 months
Metabolic health: HbA1c
大体时间:12 months
values in blood sample
12 months
Sedentary behaviour & physical activity
大体时间:12 months
measured 5 consecutive days with an accelerometer (ActiGraph GT3X+
12 months
Quality of Life EuroQol 5D
大体时间:12 months
measured by the EuroQol 5D (EQ-5D)
12 months
Quality of Life WHOQoL
大体时间:12 months
measured by the WHOQoL-Bref
12 months
Psychopathology BPRS-E
大体时间:12 months
Psychopathology / illness severity measured by the BPRS-E
12 months
Implementation fidelity
大体时间:At follow-up (12 months)
A proxy for implementation fidelity using the 'descriptive norm' item of the Measurement Instrument for Determinants of Innovations
At follow-up (12 months)

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

赞助

调查人员

  • 研究主任:Peter N van Harten, Prof. Dr.、GGZ Centraal

出版物和有用的链接

负责输入研究信息的人员自愿提供这些出版物。这些可能与研究有关。

一般刊物

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2017年7月19日

初级完成 (实际的)

2020年3月1日

研究完成 (实际的)

2020年5月17日

研究注册日期

首次提交

2017年5月8日

首先提交符合 QC 标准的

2017年5月15日

首次发布 (实际的)

2017年5月17日

研究记录更新

最后更新发布 (实际的)

2020年5月19日

上次提交的符合 QC 标准的更新

2020年5月17日

最后验证

2020年5月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • NL61552.075.17

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

药物和器械信息、研究文件

研究美国 FDA 监管的药品

研究美国 FDA 监管的设备产品

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

Lifestyle treatment的临床试验

订阅